Cesca Therapeutics Appoints Robin Stracey As Interim CEO

(RTTNews) - Cesca Therapeutics Inc. (KOOL) announced it intends to search for a new Chief Executive Officer. Robin Stracey, currently a member of the Company's Board of Directors, will serve as Interim CEO pending the new hire.

Craig Moore, Chairman of Cesca Therapeutics' Board of Directors stated, "Robin Stracey will serve as the Company's CEO in the interim, and Matthew Plavan, the Company's former CEO, will be retained as an advisor during the process."

Robin Stracey, (56) was appointed to the Board of Directors in July 2011. Stracey has been the President and Chief Executive Officer at both publicly-traded and privately held companies in the life sciences sector, including Integrated Fluidics, Inc., Cantimer Incorporated, and Applied Imaging Corporation. Stracey has also held senior executive positions at Thermo Electron Corporation, now Thermo Fisher Scientific, and Dade Behring Inc., now Siemens Healthcare.